Kevin Murphy

Kevin Murphy

Auto-generated profile, based on publicly available information

Kevin Murphy

Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2016 in arXiv
Verified
Preprint
Open access
PDF file
LCLiang-Chieh Chen
Liang-Chieh Chen
GPGeorge Papandreou
George Papandreou
IKIasonas Kokkinos
Iasonas Kokkinos
KMKevin Murphy
Kevin Murphy
AYAlan L. Yuille
Alan L. Yuille
Deep Convolutional Neural Networks (DCNNs) have recently shown state of the art performance in high level vision tasks, such as image classification and object detection. This work brings together methods from DCNNs and probabilistic graphical models for addressing the task of pixel-level classification (also called "semantic image segmentation"). We show that responses at the final layer of DCNNs are not sufficiently localized for accurate object segmentation. This is due to the very invariance properties that make DCNNs good for high level tasks. We overcome this poor localization property of deep networks by combining the responses at the final DCNN layer with a fully connected Conditional Random Field (CRF). Qualitatively, our "DeepLab" system is able to localize segment boundaries at a level of accuracy which is beyond previous methods. Quantitatively, our method sets the new state-of-art at the PASCAL VOC-2012 semantic image segmentation task, reaching 71.6% IOU accuracy in the test set. We show how these results can be obtained efficiently: Careful network re-purposing and a novel application of the 'hole' algorithm from the wavelet community allow dense computation of neural net responses at 8 frames per second on a modern GPU.

11 December 2012 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
DODavid P. O’sullivan
David P. O’sullivan
DODenis O’mahony
Denis O’mahony
CPCarole Parsons
Carole Parsons
CHCarmel Hughes
Carmel Hughes
KMKevin Murphy
Kevin Murphy
SBStephen Byrne
Stephen Byrne

12 January 2022 in Journal of Mental Health
Verified
Journal Article
Closed access
KFKate Fitzgibbon
Kate Fitzgibbon
KMKevin Daniel Murphy
Kevin Daniel Murphy
Stress in healthcare professional students is well-documented, however coping strategies and their relationship with stress has not been comprehensively reviewed. It is necessary for students to us...

17 March 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ECErin Crowley
Erin Crowley
BSBastiaan T. G. M. Sallevelt
Bastiaan T. G. M. Sallevelt
CHCorlina Johanna Alida Huibers
Corlina Johanna Alida Huibers
KMKevin D. Murphy
Kevin D. Murphy
Marco SpruitMarco Spruit
Marco Spruit
DODenis O'Mahony
Denis O'Mahony
Background: Several approaches to medication optimisation by identifying drug-related problems in older people have been described. Although some interventions have shown reductions in drug-related problems (DRPs), evidence supporting the effectiveness of medication reviews on clinical and economic outcomes is lacking. Application of the STOPP/START (version 2) explicit screening tool for inappropriate prescribing has decreased inappropriate prescribing and significantly reduced adverse drug reactions (ADRs) and associated healthcare costs in older patients with multi-morbidity and polypharmacy. Therefore, application of STOPP/START criteria during a medication review is likely to be beneficial.Incorporation of explicit screening tools into clinical decision support systems (CDSS) has gained traction as a means to improve both quality and efficiency in the rather time-consuming medication review process. Although CDSS can generate more potential inappropriate medication recommendations, some of these have been shown to be less clinically relevant, resulting in alert fatigue. Moreover, explicit tools such as STOPP/START do not cover all relevant DRPs on an individual patient level. The OPERAM study aims to assess the impact of a structured drug review on the quality of pharmacotherapy in older people with multi-morbidity and polypharmacy. The aim of this paper is to describe the structured, multi-component intervention of the OPERAM trial and compare it with the approach in the comparator arm.Method: This paper describes a multi-component intervention, integrating interventions that have demonstrated effectiveness in defining DRPs. The intervention involves a structured history-taking of medication (SHiM), a medication review according to the systemic tool to reduce inappropriate prescribing (STRIP) method, assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2), followed by shared decision-making with both patient and attending physician. The developed method integrates patient input, patient data, involvement from other healthcare professionals and CDSS-assistance into one structured intervention.Discussion: The clinical and economical effectiveness of this experimental intervention will be evaluated in a cohort of hospitalised, older patients with multi-morbidity and polypharmacy in the multicentre, randomized controlled OPERAM trial (OPtimising thERapy to prevent Avoidable hospital admissions in the Multi-morbid elderly), which will be completed in the last quarter of 2019.Trial registration: Universal Trial Number:U1111-1181-9400Clinicaltrials.gov:NCT02986425, Registered 08 December 2016.FOPH (Swiss national portal):SNCTP000002183. Netherlands Trial Register:NTR6012(07-10-2016).

9 July 2013 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
CPCarole Parsons
Carole Parsons
NMNoleen McCorry
Noleen McCorry
KMKevin Murphy
Kevin Murphy
SBStephen Byrne
Stephen Byrne
DODavid O'SUllivan
David O'SUllivan
CHCarmel Hughes
Carmel Hughes

29 March 2022 in BMJ Quality & Safety
Verified
Journal Article
Open access
PDF file
STStefanie Thevelin
Stefanie Thevelin
CPCatherine Pétein
Catherine Pétein
BMBeatrice Metry
Beatrice Metry
LALuise Adam
Luise Adam
AHAnniek van Herksen
Anniek van Herksen
ODOlivia Dalleur
Olivia Dalleur
Background A patient-centred approach to medicines optimisation is considered essential. The OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial evaluated the effectiveness of medication review with shared decision-making (SDM) in older people with multimorbidity. Beyond evaluating the clinical effectiveness, exploring the patient experience facilitates a better understanding of contextual factors and mechanisms affecting medication review effectiveness. Objective To explore experiences of hospital-initiated medication changes in older people with multimorbidity. Methods We conducted a multicentre mixed-methods study, embedded in the OPERAM trial, combining semi-structured interviews and the Beliefs about Medicines Questionnaire (BMQ) with a purposive sample of 48 patients (70–94 years) from four European countries. Interviews were analysed using the Framework approach. Trial implementation data on SDM were collected and the 9-item SDM questionnaire was conducted with 17 clinicians. Results Patients generally displayed positive attitudes towards medication review, yet emphasised the importance of long-term, trusting relationships such as with their general practitioners for medication review. Many patients reported a lack of information and communication about medication changes and predominantly experienced paternalistic decision-making. Patients’ beliefs that ‘doctors know best’, ‘blind trust’, having limited opportunities for questions, use of jargon terms by clinicians, ‘feeling too ill’, dismissive clinicians, etc highlight the powerlessness some patients felt during hospitalisation, all representing barriers to SDM. Conversely, involvement of companions, health literacy, empathetic and trusting patient-doctor relationships, facilitated SDM. Paradoxical to patients’ experiential accounts, clinicians reported high levels of SDM. The BMQ showed that most patients had high necessity and low concern beliefs about medicines. Beliefs about medicines, experiencing benefits or harms from medication changes, illness perception, trust and balancing advice between different healthcare professionals all affected acceptance of medication changes. Conclusion To meet patients’ needs, future medicines optimisation interventions should enhance information exchange, better prepare patients and clinicians for partnership in care and foster collaborative medication reviews across care settings.